GSK to pay Chimagen $300m upfront to develop autoimmune drug
GSK Plc., will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.
Drugs
Health
Medical
Drugs
Health
Pharma
GSK to invest $800 million in US to double capacity at Marietta facility
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to.
Drugs
Health
Pharma
GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.
Drugs
Health
Pharma
US regulator allows GSK’s endometrial cancer therapy for expanded use
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.
Drugs
Health
Pharma
GSK’s blood cancer test drug halves risk of disease progression: Data
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a.
Drugs
Health
Pharma
First late-stage trial vaccine doses begin in South Africa for tuberculosis
HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.
Drugs
Health
Pharma
GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion
HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.
Drugs
Health
Pharma
GSK Plc gets EU approval for HIV prevention drug Apretude
GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.
Drugs
Health
Pharma
USFDA gives nod for GSK’s Ojjaara bone cancer therapy
The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.